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We aimed to identify the clinical and echocardiographic determinants of symptoms and their
prognostic implications in patients with moderately dysfunctional bicuspid aortic valves
(BAVs).
Methods
Among 1,019 subjects in the BAV registry treated in a single tertiary care center, the rec-
ords of 127 patients (85 men, age 58±13 years) with moderately dysfunctional BAVs were
comprehensively reviewed. The patients were divided into two groups based on symptom
status: asymptomatic (n = 80) vs. symptomatic (n = 47). The primary end-point was
defined as a composite of aortic valve surgery, hospitalization for heart failure, and any
cause of death.
Results
The symptomatic group had a higher proportion of females, hypertension, aortic stenosis,
and aortopathy than did the asymptomatic group. The symptomatic group showed lower e0
(5.5±1.7 vs. 6.5±2.2 cm/s, p = 0.003), higher E/e0 (13.3 ± 4.9 vs. 10.9±3.7, p = 0.002), and
larger left atrial volume index (29.9±11.4 vs. 24.6±9.1 ml/m2, p = 0.006) than did the asymp-
tomatic group. In multivariate logistic regression analysis, female gender (odds ratio [OR]
2.84, 95% confidence interval [CI] 1.10–7.36, p = 0.031), hypertension (OR 3.07, 95% CI
1.20–7.82, p = 0.019), moderate aortic stenosis (OR 5.33 5.78, 95% CI 1.99–16.83, p =
0.001), E/e0 >15 (OR 3.82, 95% CI 1.03–11.19, p = 0.015), and aortopathy (OR 2.76, 95%
CI 1.07–7.10, p = 0.035) were independently correlated with symptom status. The symptom-
atic group showed a significantly lower rate of event-free survival during the 8-year follow-up
period (54±9% vs. 68±10%, p = 0.001).
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Conclusions
In patients with moderately dysfunctional BAVs, the presence of moderate aortic stenosis,
aortopathy, and diastolic dysfunction determines symptom status, along with female gender
and hypertension. Symptom status was associated with clinical outcomes.
Introduction
Bicuspid aortic valve (BAV) is known to frequently progress to aortic valve stenosis (AS) and
aortic regurgitation, requiring aortic valve replacement (AVR). Furthermore, dilatation of the
aortic root and/or the ascending aorta (AA) occurs more frequently in patients with a bicuspid
aortic valve (BAV) than in patients with a tricuspid aortic valve (TAV). Recent studies have
demonstrated that left ventricular (LV) diastolic function is impaired in subjects with a nor-
mally functioning BAV as compared to subjects with a TAV, and LV diastolic dysfunction is
associated with aortic dilatation and consequent aortic stiffness [1–4]. However, the clinical
implications of diastolic dysfunction in BAV subjects with aortopathy are uncertain.
In patients with moderate to severe aortic stenosis (AS) or aortic regurgitation (AR), LV
hypertrophy and diastolic dysfunction are quite commonly caused by chronic pressure or vol-
ume overload and LV hypertrophy is related to impaired relaxation and increased LV chamber
stiffness [5,6].
The occurrence of symptoms and adverse events are most likely related to the global hemo-
dynamic burden faced by the ventricle [7]. This global load not only includes the valvular load,
but also the pulsatile and steady components of arterial load, which are related to reduced arte-
rial compliance and increased vascular resistance [7]. Recently, the clinical importance of dia-
stolic dysfunction in patients with severe AS has been highlighted with regards to understanding
symptom status and predicting clinical outcomes [8,9]. Moreover, the importance of valvular,
arterial, and ventricular interplay in AV disease has been suggested for improving risk stratifica-
tion and identifying patients who could benefit from early elective aortic valve surgery [10].
Increased aortic stiffness is independently associated with elevated LV filling pressure, plasma
brain natriuretic peptide level, and symptom severity in AS [11].
Therefore, we hypothesised that 1) the presence of symptoms is determined by BAV pheno-
type or function, aortic phenotype, or LV diastolic function in patients with moderately
dysfunctional BAVs, and 2) symptomatic patients show worse clinical outcomes than do
asymptomatic patients. In order to test our hypotheses, we reviewed clinical and echocardio-
graphic characteristics and clinical events in patients with moderately dysfunctional BAVs.
Materials and Methods
Patient population
We retrospectively reviewed the echocardiographic database and medical records of patients
with BAVs who were diagnosed from 2003 to 2015 at Severance Cardiovascular Hospital
(Yonsei University College of Medicine, Seoul, Republic of Korea). During this period, a total
of 1,019 patients with BAVs were identified. Among them, 208 patients who had moderate AS
and/or AR evident on a transthoracic echocardiogram defined using the guidelines in place
[12,13] at the time of diagnosis were included in our study. All patients diagnosed with severe
AS and/or AR by echocardiogram were excluded. Patients who had coronary artery disease,
defined as>50% narrowing in at least one coronary artery on an angiogram (n = 38), an LV
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ejection fraction<50% (n = 18), previous open heart surgery (n = 4), concomitant other valvu-
lar diseases of moderate or severe status (n = 6), infective endocarditis (n = 6), hypertrophic
cardiomyopathy (n = 4), end-stage renal disease (n = 4), and chronic obstructive lung disease
(n = 1) were excluded. Therefore, 127 patients (mean age 58±13 years, 85 men) were ultimately
included in this study. All patients’ medical records, which were recorded by physicians, were
carefully reviewed by a single cardiologist. History of cardiac symptoms, including dyspnoea
according to New York Heart Association classes, angina, syncope, or presyncope, were
reported at the time of the initial clinical and echocardiographic evaluation. Based on their
presenting symptoms, including chest pain, dyspnoea, or syncope, the study population was
divided into two groups: asymptomatic (n = 80, 63%) vs. symptomatic (n = 47, 37%) (Fig 1).
The Institutional Review Board of Yonsei University College of Medicine approved the present
study, which was conducted in compliance with the Declaration of Helsinki.
Echocardiographic assessments
Standard two-dimensional and Doppler measurements were performed following American
Society of Echocardiography guidelines [14]. A congenital BAV was diagnosed when only two
cusps were unequivocally identified in systole and diastole in the short-axis view, with a clear
‘‘fish mouth” appearance during systole, as previously described [3]. We classified two BAV
phenotypes based on the orientation of the free edge of the cusp, defined as the anterior-poste-
rior and right-left forms of BAV (BAV-AP and BAV-RL, respectively) [15]. The severity of AS
or AR were assessed using an integrated approach [16,17]. All measurements of the aorta were
performed according to the recommendations on the QRS complex of the electrocardiogram
[18]. The dimensions of the Valsalva sinuses were measured perpendicular to the right and left
(or non-) aortic sinuses. The sinotubular junction was measured where the aortic sinuses met
the tubular aorta. The AA was measured approximately 2 cm distal to the sinotubular junction,
as described previously [3]. Aortopathy was defined as a predominant dilatation of the Val-
salva sinuses or AA. Three aortic phenotypes were identified: (1) normal shape (Valsalva
sinuses <39 mm and AA<Valsalva); (2) predominant dilatation of the Valsalva sinuses (Val-
salva39 mm and Valsalva>AA); and (3) predominant dilatation of the AA (AA39 mm
and AA>Valsalva). End-systolic pressure was estimated as systolic blood pressure ×0.9, as
described previously [19–21]. The effective arterial elastance (Ea), a global marker of arterial
stiffness that encompasses both steady and pulsatile arterial load, was calculated as the end-
systolic pressure divided by the stroke volume [19–21]. To assess global LV afterload in AS
patients, valvulo-arterial impedance (Zva) was calculated using a previously validated method
[22]. Echocardiographic data were gathered and analyzed by experienced echocardiographers
who were unaware of each patient’s clinical data.
Follow-up
Follow-up information was obtained via a review of the medical records. The primary end-
point was a composite of death, hospitalization for heart failure, and AV replacement. The clin-
ical management of the patients was determined independently by their personal cardiologists.
Statistical analysis
Data are presented as mean ± standard deviation or percentage unless otherwise specified. Dif-
ferences between groups were compared using the Student’s t-test, and categorical variables
were tested by Fisher’s exact test or Pearson’s chi-square test. In order to determine indepen-
dent correlates of e0 velocity and aortic mechanical and functional properties, linear relations
were verified using a simple linear regression analysis. Multiple logistic regression analysis was
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performed to assess the independent determinants for the presence of symptoms. All variables
with suspected clinical relevance were entered, and variables were adjusted for age, gender,
body mass index, and a history of hypertension or diabetes mellitus. Their incremental value
was assessed by comparing the global Chi-square values for each model. The Kaplan-Meier
method was used for cumulative survival analysis with the log-rank test for assessing the statis-
tical differences between the two groups according to the presence of each symptom. A two-
sided p-value less than 0.05 was considered statistically significant.
Results
Demographic characteristics
The demographic characteristics of the patients according to symptom status are presented in
Table 1. Among 128 patients, 80 (63%) patients were asymptomatic, and 47(37%) patients
were symptomatic. Although there were no significant differences in age, body mass index,
Fig 1. Description of the study population.
doi:10.1371/journal.pone.0169285.g001
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systolic blood pressure, or pulse pressure between the two groups, the symptomatic group had
a higher proportion of females, hypertension, and use of diuretics than did the asymptomatic
group. The major cause of symptoms in the symptomatic patients was dyspnea (63.8%), but
New York Heart Association (NYHA) class III or IV dyspnea was rare (4.3%).
Echocardiographic characteristics
Table 2 shows the echocardiographic characteristics of the two groups. Of the patients with
moderately dysfunctional BAVs, approximately one-third of patients displayed the A-P type of
BAV, and there was no difference in the prevalence of the BAV phenotype between the two
groups. The symptomatic group had a higher prevalence of moderate AS than did the asymp-
tomatic group (72.3 vs. 43.8%, p = 0.003). Accordingly, a greater number of moderate AR
patients were classified into the asymptomatic group.
Symptomatic patients showed a significantly higher prevalence of aortopathy than did
asymptomatic patients (70.2 vs. 47.5%, p = 0.016). Among the three aortic phenotypes, there
was a significantly higher prevalence of predominant AA in the symptomatic group than in
the other group (59.6 vs. 37.5%, p = 0.018). Aortic diameters tended to be larger in patients
Table 1. Baseline clinical characteristics.
Asymptomatic (n = 80) Symptomatic (n = 47) p-value
Age, years 57±14 59±12 0.358
Female 19(23.8) 23(48.9) 0.006
Body mass index, kg/m2 23.3±4.6 24.1±3.0 0.253
Systolic BP, mmHg 123.9±14.7 128.3±18.2 0.143
Diastolic BP, mmHg 75.6±9.7 81.3±12.4 0.005
Pulse pressure, mmHg 48.3±12.1 47.0±12.5 0.566
Hemoglobin, g/dl 13.5±1.9 12.6±1.93 0.184
Creatinine, mg/dl 0.95±0.32 1.02±0.59 0.413
EGFR, ml/min/1.73m2 80.7±22.6 78.2±19.8 0.319
Co-morbidities
Hypertension 22 (27.5) 24 (51.1) 0.012
Diabetes mellitus 10 (12.5) 9 (19.1) 0.316
Dyslipidemia 8 (10.0) 10 (21.3) 0.113
Atrial fibrillation 4(5.0) 4 (8.5) 0.467
Chronic kidney disease 6(7.5) 6(12.8) 0.358
Medications
Diuretics 13(16.3) 17 (36.2) 0.017
β-blocker 8 (10.0) 11(23.4) 0.069
CCB 12(15.0) 9 (19.1) 0.623
ACEi/ARB 37(46.3) 22 (46.8) 1.000
Symptoms
Chest pain, or discomfort 0 15(31.9)
Dyspnea
NHYA Class (1/2/3/4) 80(100)/0/0/0 15(31.9)/30(63.8)/2(4.3)/0
Pre-syncope, or syncope 0 4(8.5)
Values are mean (±SD), number of subjects (%). ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BP, blood pressure;
CCB, calcium channel blocker; COPD, chronic obstructive pulmonary disease; EGFR, estimated glomelular filtration rate; NYHA, New York Heart
Association. Chronic kidney disease was defined as creatinine clearance <60 ml/min.
doi:10.1371/journal.pone.0169285.t001
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with symptoms than in those without symptoms at the site of the tubular portion of the AA,
with marginal statistical significance. In terms of noninvasively derived arterial stiffness, the
effective arterial elastance was significantly higher in symptomatic patients than in those with-
out symptoms (1.8±0.4 vs. 1.5±0.5 mmHg/ml, p = 0.003). Likewise, valvulo-arterial impedance
calculated in AS patients (n = 85) was higher in the symptomatic group (4.7±1.7 vs. 3.9±1.3
mmHg/ml/m2, p = 0.013).
Table 2. Echocardiographic characteristics.
Asymptomatic (n = 80) Symptomatic (n = 47) p-value
BAV phenotype, n (%)
A-P type 55 (68.8) 30 (63.8) 0.696
R-L type 25 (31.3) 17 (36.2)
BAV dysfunction, n (%)
Moderate AS 35 (43.8) 35 (72.3) 0.003
Moderate AR 36 (45.0) 7 (14.9) <0.001
Moderate AS with AR 9 (11.3) 6 (12.8) 0.784
Aorta phenotype, n (%)
Overall aortopathy 38 (47.5) 33(70.2) 0.016
Normal shape 42 (52.5) 14 (29.8) 0.016
Predominant sinus Valsalva 8 (10.0) 5 (10.6) 1.000
Predominant ascending aorta 30 (37.5) 28 (59.6) 0.018
Aorta dimension, mm
Sinus of Valsalva 34.3 ± 5.1 34.5± 5.1 0.928
Sinotubularjunction 29.9 ± 4.7 30.4 ±4.4 0.533
Tubular portion of AA 38.6 ± 6.2 40.8 ± 6.1 0.057
Effective arterial elastance, mmHg/ml 1.5 ± 0.5 1.8 ± 0.4 0.003
Valvuloarterial impedance, mmHg/ml/m2 3.9±1.3 4.7±1.7 0.013
Echocardiography data
Aortic valve area, cm2 1.25 ± 0.41 1.19 ± 0.38 0.521
Mean pressure gradient, mmHg 28 ± 7 30 ± 6 0.238
LVEDD, mm 51.3 ±5.3 49.0 ±4.6 0.019
LVESD, mm 33.1 ± 5.1 32.0 ±5.8 0.291
LAVI, ml/m2 24.6 ±9.1 29.9 ±11.4 0.006
RWT 0.39 ±0.06 0.42 ±0.07 0.036
LVMI, g/m2 111.5 ± 21.7 109.4 ± 25.6 0.612
LVEF, % 67.0 ± 5.9 67.2 ±6.4 0.883
E velocity, m/s 0.66±0.18 0.68±0.22 0.518
Deceleration time, msec 215 ±41 216 ±40 0.918
A velocity, m/s 0.71±0.19 0.76 ±0.22 0.231
e’ velocity, cm/s 6.5 ±2.2 5.5 ±1.7 0.003
A’ velocity, cm/s 8.6 ±1.7 8.0 ±1.7 0.105
S’ velocity, cm/s 6.7 ±1.4 5.9 ±1.5 0.003
E/e’ 10.9 ±3.7 13.3 ± 4.9 0.002
RVSP, mmHg 25.6 ± 5.7 27.2 ± 6.3 0.179
Values are mean (±SD). LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; IVSD, interventricualrseptal diameter;
LVPWD, left ventricular posterior wall diameter; LAVI, left atrial voumeindex; RWT, relative wall thickness; LVMI, left ventricular mass index; LVEF, left
ventricular ejection fraction; E, early diastolic mitral inflow; e’, early diastolic mitral annular; A, late diastolic mitral inflow; A’, late diastolic mitral annular; S’
peak systolic mitral annular; RVSP, Right ventricular systolic function.
doi:10.1371/journal.pone.0169285.t002
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Symptomatic patients had a smaller LV end-diastolic dimension and higher relative wall
thickness than did asymptomatic patients. There were no significant differences in LV mass
index or LV ejection fraction (LVEF). The symptomatic group was found to possess more
advanced LV diastolic dysfunction with a larger left atrium volume index, a lower e‘velocity,
and a higher E/e0 ratio than the asymptomatic group. Regarding the vascular-ventricular inter-
action, there were significant correlations between the structural and functional properties of
the AA and LV diastolic indices. The AA diameters were well correlated with e0 velocity (r =
-0.368, p<0.001) and E/e0 (r = 0.179, p = 0.044). The effective arterial elastance also revealed
significant correlations with e0 velocity (r = -0.202, p = 0.023) and E/e0 (r = 0.182, p = 0.041).
Determinants of symptomatic status
The percentages of patients with symptoms according to gender, moderate AS, or aortopathy
are given in Fig 2. In patients with moderate AS, female patients displayed a higher rate of
symptom presentation (62.5 vs. 37.5%, p = 0.043) and had a higher E/e0 (13.6±4.8 vs. 11.5±3.6,
p = 0.030) than did male patients. In patients with aortopathy, female patients had a higher E/
e0 (13.6±4.4 vs. 11.3±4.2, p = 0.036) than did male patients. However, although male patients
overall had a lower prevalence of symptoms than did female patients, male patients with
moderate AS or aortopathy had dramatic increases in symptom presentation (p = 0.013 and
p = 0.007, respectively).
Female gender, moderate AS, and the presence of aortopathy were predictive of symptom-
atic status in patients with moderately dysfunctional BAVs, even when taking into account a
combination of clinical variables, including age, body mass index, and the presence of hyper-
tension or diabetes mellitus (Fig 3).
When adjusting for confounding factors in the multivariate logistic regression analysis,
female gender (odds ratio [OR] 2.84, 95% confidence interval [CI] 1.10–7.36, p = 0.031),
hypertension (OR 3.07, 95% CI 1.20–7.82, p = 0.019), moderate AS (OR 5.33 5.78, 95% CI
1.99–16.83, p = 0.001), aortopathy (OR 2.76, 95% CI 1.07–7.10, p = 0.035), and E/e0 >15 (OR
3.82, 95% CI 1.03–11.19, p = 0.015) were associated with the symptomatic status of moderately
dysfunctional BAV (Table 3).
Prognostic significance of symptomatic status
During a mean 41 ± 27 months of follow-up, adverse clinical events occurred in 31 (24.4%)
patients (Table 4). In symptomatic patients compared to asymptomatic patients, AV surgery
was performed more frequently (31.9 vs. 12.5%, p = 0.011) during the follow up period. AV
surgery was underwent owing to symptomatic moderate AS (7 patients (14.9%)). Progression
to severe AS was found in 8 patients (17.0%) in symptomatic group and 10 patients (12.5%)
were in asymptomatic group (p = 0.481). The hospitalization for heart failure occurred more
often in symptomatic patients (14.9% vs. 3.8%, p = 0.038). The LVEF of patients with hospitali-
zation for heart failure was preserved (mean LVEF 65 ±5%).
There was no significant difference in all-cause mortality between the two groups. The pres-
ence of symptoms was associated with reduced event-free survival during the follow-up period
(54±9% vs. 68±10%, log-rank p = 0.001) (Fig 4).
Discussion
The principal findings of the present study are that 1) symptoms are more prevalent in female
patients, patients with hypertension, moderate AS, or aortopathy in association with conse-
quent LV diastolic dysfunction in patients with moderately dysfunctional BAVs, and 2) more
severe symptomatic status in patients with moderately dysfunctional BAVs was associated
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with poorer clinical outcomes. The results of our study demonstrate the clinical importance of
BAV aortopathy in conjunction with other clinical factors that may affect increased LV after-
load and consequent LV diastolic dysfunction. Therefore, risk stratification, careful follow-up,
and identification of candidates for early AV surgery are necessary in patients with moderately
dysfunctional BAVs.
Pathologic hypertrophy can lead to coronary microvascular dysfunction despite angio-
graphically unobstructed coronary arteries [23]. When ventricular dilatation becomes detect-
able, pathological alterations such as reduced coronary blood flow per myocardial mass have
already occurred [24]. A recent study demonstrated that coronary microvascular dysfunction
is a main contributing factor to the development of chest pain in patients with severe AS with-
out obstructive coronary artery disease [25]. Severe AS and LV remodelling reduce myocardial
Fig 2. Presence of symptoms and E/e0 according to gender, BAV function, and aortopathy.
doi:10.1371/journal.pone.0169285.g002
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blood flow in the subendocardium, and reduction of flow is related to increased apoptosis of
cardiomyoctes, which leads to heart failure [26]. Although coronary microvascular dysfunc-
tion has not been well established for explaining chest pain in moderate AS as much as in
severe AS, it can exist in patients with moderate AS combined with increased LV afterload and
consequent LV diastolic dysfunction.
The importance of heart failure with preserved ejection fraction is increasingly being recog-
nised [27,28]. Patients with these conditions most likely develop heart failure owing to LV dia-
stolic dysfunction. They tend to be older, to be female, and to have a history of hypertension
[27,28]. Central aortic stiffness and the ventricular response to elevated LV afterload are highly
linked to the pathogenesis of heart failure with preserved ejection fraction [21,29,30]. If there
is AV disease in subjects who are vulnerable to heart failure, symptoms may occur more easily
because of further pressure and volume overload in the LV. Moreover, if subjects with AV dis-
ease have dilatation of the proximal aorta and consequent central aortic stiffness, symptoms
related to heart failure or AV disease can be further aggravated. In this study, the complaint
symptoms of the 37% of patients with moderately dysfunctional BAVs were related to heart
failure or AV disease. Symptomatic patients included more female patients and those with a
higher prevalence of hypertension. Our results are in accordance with the generally proven
risk factors for heart failure with preserved ejection fraction [27,28]. Symptomatic patients in
this study possessed significantly elevated effective arterial elastance and valvulo-arterial
impedance than did asymptomatic patients. Therefore, vascular stiffening combined with
Fig 3. Incremental values for the presence of moderate AS and aortopathy in addition to clinical variables for the prediction of
symptom status in patients with moderately dysfunctional BAVs.
doi:10.1371/journal.pone.0169285.g003
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elevated systolic loads from AV disease, especially in moderate AS, may contribute to the clini-
cal features of patients with moderately dysfunctional BAVs. Furthermore, symptomatic
patients showed worse clinical outcomes than did asymptomatic patients. Even though the
higher prevalence of symptomatic patients was probably influenced by the characteristics of
the study population enrolled in a single tertiary care center, the present data showed a prog-
nostic difference according to symptom status.
Several possible mechanisms can be suggested regarding the gender difference in symptom
status in patients with moderately dysfunctional BAVs. In a previous study of 408 consecutive
patients with isolated severe AS undergoing AV replacement, women were more symptomatic
than men, but the affected women were also older and had smaller valve areas and higher
mean pressure gradients than did the men [31]. Female patients were more symptomatic than
male patients (23/42, 54.8% vs. 24/85, 28.2%, p = 0.006), even though the indexed AV area
(0.73±0.24 vs. 0.73±0.22 cm2/m2, p = 0.936) and mean pressure gradient across the AV
Table 3. Determinants of symptom status in univariate and multivariate logistic regression analyses.
Univariable Multivariable
OR (95% CI) p-value OR (95% CI) p-value
Clinical characteristics
Age 1.01 (0.99–1.04) 0.355 0.98 (0.94–1.02) 0.260
Female 3.08 (1.43–6.64) 0.004 2.84 (1.10–7.36) 0.031
Body mass index 1.05 (0.96–1.16) 0.271 1.02 (0.92–1.13) 0.772
Hypertension 2.75 (1.30–5.85) 0.008 3.07 (1.20–7.82) 0.019
Diabetes mellitus 1.66 (0.62–4.31) 0.314 0.60 (0.16–2.31) 0.602
Echocardiographic characteristics
BAV phenotype (A-P type) 1.25 (0.58–2.67) 0.570
Moderate AS 4.68 (1.87–11.68) 0.001 5.78 (1.99–16.83) 0.001
Moderate AR 0.21 (0.09–0.53) 0.001
AA dimension (mm) 1.06 (0.99–1.12) 0.060
Presence of aortopathy 2.61 (1.21–5.59) 0.014 2.76 (1.07–7.10) 0.035
LVEF 1.01 (0.95–1.07) 0.882 0.95 (0.88–1.03) 0.215
LVMI 0.99 (0.98–1.01) 0.609 0.99(0.97–1.01) 0.483
LAVI 1.05 (1.01–1.09) 0.013
E/e’ 1.14 (1.04–1.25) 0.004
e’ velocity 0.77 (0.63–0.94) 0.010
E/e’>15 2.61 (1.21–5.59) 0.014 3.82 (1.03–11.19) 0.015
OR, odds ratio; CI, confidence interval; BAV, bicuspid aortic valve; A-P, anterior-posterior; AS, aortic stenosis; AR, aortic regurgitation; AA, ascending
aorta; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass index; LAVI, left atrial volume index; E, early diastolic mitral inflow; e’, early diastolic
mitral annular
doi:10.1371/journal.pone.0169285.t003
Table 4. Clinical outcomes according to symptom status.
Asymptomatic (n = 80) Symptomatic (n = 47) p-value
Composite outcome 14(17.5) 17(36.2) 0.031
Aortic valve surgery 10 (12.5) 15 (31.9) 0.011
Surgery for aortic valve only 3(3.8) 7 (14.9) 0.038
Surgery for aortic valve and aortic root 7 (8.8) 8 (17.0) 0.254
Hospitalization for heart failure 3 (3.8) 7 (14.9) 0.038
All-cause mortality 4 (5.0) 2 (4.3) 1.000
doi:10.1371/journal.pone.0169285.t004
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(28.4±6.9 vs. 29.9±5.8 mmHg, p = 0.311) did not differ by gender in the present study popula-
tion. Female patients with moderately dysfunctional BAVs displayed more impaired LV dia-
stolic functional parameters, including e0 velocity (5.6±1.9 vs. 6.5±2.2 cm/s, p = 0.026) and E/e0
(13.2±4.6 vs. 11.1±4.1, p = 0.011), compared to male patients. Our results are consistent with
those of a few previous studies that demonstrated the importance of diastolic dysfunction on
symptom status in severe AS, although the previous studies did not show gender-specific dif-
ferences [8,32].
Previous studies reported that LV longitudinal relaxation was significantly impaired and
estimated LV filling pressure was elevated in BAV subjects without significant valvular dys-
function [1,3,4]. There is a noticeable increase in central aortic stiffness in BAV subjects
compared with TAV controls [2]. Moreover, independent correlations between the parame-
ters of LV diastolic function and the indices of aortic mechanical function have been
established in subjects with BAV [3]. Consistently, the present study demonstrated good
correlations between the structural and functional properties of the AA and LV diastolic
indices. We believe that valvular, arterial, and ventricular interplay is more important in
patients with moderately dysfunctional BAVs than in subjects with normally functioning
BAVs because either diastolic dysfunction or aortic stiffness may result in substantial clini-
cal events.
Fig 4. Kaplan-Meier survival curves showing a poorer prognosis of patients with symptoms compared to those without.
doi:10.1371/journal.pone.0169285.g004
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Limitations
There are several limitations to this study. First, the present study is a retrospective analysis;
thus, an assessment of symptoms is dependent upon the accuracy of the medical records.
Symptomatic patients were evaluated according to their NYHA class. We could not exclude
patients who had occult coronary artery diseases, if those did not undergo evaluation of the
coronary arteries. There were no objective tests for assessing exercise capacity in the present
study. However, the mean age of the study population was 58±13 years-old; therefore, we sus-
pect that the number of patients who were asymptomatic because they avoided physical activi-
ties would not represent a large portion of our patients. Second, this study was conducted in a
tertiary care center, which raises the possibility that the study population may have a higher
prevalence of co-morbidities than the general population. However, the prevalence of hyper-
tension, the most important co-morbid condition influencing the results, was not high
(36.2%). In addition, patients with coronary artery disease or specific co-morbidities influenc-
ing clinical outcomes were excluded. Third, this study included moderate AS with AR patients.
Mixed aortic valve disease is found to be associated with a high rate of adverse events in
patients with tricuspid aortic valves [33]. However, the prevalence of moderate AS with AR
was not significantly different between the groups (11.3% vs. 12.8%, p = 0.784). Fourth, classifi-
cation of aortopathy and evaluation of mechanical function only depended on the results of
transthoracic echocardiography, although recent studies suggest that multidetector computed
tomography or magnetic resonance imaging allows for an appropriate assessment of the extent
of aortopathy and functional alteration of the aorta [34].
Conclusions
In patients with moderately dysfunctional BAVs, symptom status is independently associated
with female gender; the presence of hypertension, moderate AS, or aortopathy; and conse-
quent LV diastolic dysfunction. Moreover, the presence of symptoms in moderately dysfunc-
tional BAV patients is associated with worse clinical outcomes.
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